상세 보기
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19 -17)
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19 -17)
- 제목
- A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19 -17)
- 제목 (타언어)
- A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19 -17)
- 저자
- Kang Eun Joo
- 발행일
- 2023-09-23
- 학회명
- ESMO 2023 Congress
- 개최국가
- 스페인
- 학회 개최일
- 2023-10-20 ~ 2023-10-24